Movement Disorders (revue) - Exploration (Accueil)

Index « Keywords » - entrée « Huntington Disease (drug therapy) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Huntington Disease (diet therapy) < Huntington Disease (drug therapy) < Huntington Disease (enzymology)  Facettes :

List of bibliographic references indexed by Huntington Disease (drug therapy)

Number of relevant bibliographic references: 40.
[0-20] [0 - 20][0 - 40][20-40]
Ident.Authors (with country if any)Title
000292 (2015) Raymond Y. Lo [Taïwan] ; Karla P. Figueroa ; Stefan M. Pulst ; Chi-Ying Lin ; Susan Perlman ; George Wilmot ; Christopher Gomez ; Jeremy Schmahmann ; Henry Paulson ; Vikram G. Shakkottai ; Sarah Ying ; Theresa Zesiewicz ; Khalaf Bushara ; Michael Geschwind ; Guangbin Xia ; S H Subramony ; Tetsuo Ashizawa ; Sheng-Han KuoCoenzyme Q10 and spinocerebellar ataxias.
000345 (2015) Adriana Prundean [France] ; Katia Youssov ; Sandrine Humbert ; Dominique Bonneau ; Christophe VernyA phase II, open-label evaluation of cysteamine tolerability in patients with Huntington's disease.
000557 (2014) S. Tunc ; P. Capetian ; Alexander MünchauHope for Huntington's disease? A novel approach for disease modification.
000732 (2013) Ralf Reilmann [Allemagne]The pridopidine paradox in Huntington's disease.
000793 (2013) Leigh J. Beglinger [États-Unis] ; William H. Adams [États-Unis] ; Douglas Langbehn [États-Unis] ; Jess G. Fiedorowicz [États-Unis] ; Ricardo Jorge [États-Unis] ; Kevin Biglan [États-Unis] ; John Caviness [États-Unis] ; Blair Olson [États-Unis] ; Robert G. Robinson [États-Unis] ; Karl Kieburtz [États-Unis] ; Jane S. Paulsen [États-Unis]Results of the Citalopram to Enhance Cognition in Huntington Disease Trial
000845 (2013) Ralf Reilmann [Allemagne]Pharmacological treatment of chorea in Huntington’s disease–good clinical practice versus evidence-based guideline
000B04 (2013) Raja Mehanna [États-Unis] ; Christine Hunter ; Anthony Davidson ; Joohi Jimenez-Shahed ; Joseph Jankovic [États-Unis]Analysis of CYP2D6 genotype and response to tetrabenazine.
000B26 (2013) A randomized, double-blind, placebo-controlled trial of pridopidine in Huntington's disease.
000C23 (2012) Leslie J. Cloud [États-Unis] ; Adam Rosenblatt ; Russel L. Margolis ; Christopher A. Ross ; Jagan A. Pillai ; Jody Corey-Bloom ; Hannah M. Tully ; Thomas Bird ; Peter K. Panegyres ; Charles A. Nichter ; Donald S. Higgins ; Sandra L. Helmers ; Stewart A. Factor ; Randi Jones ; Claudia M. TestaSeizures in juvenile Huntington's disease: frequency and characterization in a multicenter cohort.
000C63 (2012) Charles S. Venuto [États-Unis] ; Andrew Mcgarry ; Qing Ma ; Karl KieburtzPharmacologic approaches to the treatment of Huntington's disease.
001908 (2010) Gonzalo J. Revuelta [États-Unis] ; Claudia Testa [États-Unis] ; James G. Greene [États-Unis]Writer's cramp: A potential early feature of Huntington's disease
001A20 (2010) Safety and tolerability of high‐dosage coenzyme Q10 in Huntington's disease and healthy subjects
001B58 (2010) Maximilian Gahr [Allemagne] ; Michael Orth [Allemagne] ; Birgit Abler [Allemagne]Neuroleptic malignant syndrome with aripiprazole in Huntington's disease
001E89 (2010) Cudkowicz [États-Unis]A futility study of minocycline in Huntington's disease
002007 (2009) Livia Brusa [Italie] ; Antonio Orlacchio [Italie] ; Vincenzo Moschella [Italie] ; Cesare Iani [Italie] ; Giorgio Bernardi [Italie] ; Nicola Biagio Mercuri [Italie]Treatment of the symptoms of Huntington's disease: Preliminary results comparing aripiprazole and tetrabenazine
002473 (2009) Adrienne Curtis [Royaume-Uni] ; Ian Mitchell [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Natalie Ives [Royaume-Uni] ; Hugh Rickards [Royaume-Uni]A pilot study using nabilone for symptomatic treatment in Huntington's disease
002691 (2008) Zulema Salazar [Argentine] ; Lorena Tschopp [Argentine] ; Cristian Calandra [Argentine] ; Federico Micheli [Argentine]Pisa syndrome and Parkinsonism secondary to valproic acid in Huntington's disease
002A40 (2008) Josef Priller [Allemagne] ; Daniel Ecker [Allemagne] ; Bernhard Landwehrmeyer [Allemagne] ; David Craufurd [Royaume-Uni]A Europe‐wide assessment of current medication choices in Huntington's disease
002B67 (2007) Penelope Hogarth [États-Unis] ; Luca Lovrecic [États-Unis] ; Dimitri Krainc [États-Unis]Sodium phenylbutyrate in Huntington's disease: A dose‐finding study
002B80 (2007) Christopher Kenney [États-Unis] ; Christine Hunter [États-Unis] ; Anthony Davidson [États-Unis] ; Joseph Jankovic [États-Unis]Short‐term effects of tetrabenazine on chorea associated with Huntington's disease
002B82 (2007) Carmine Vitale [Italie] ; Stefano Marconi [Italie] ; Luigi Di Maio [Italie] ; Giuseppe De Michele [Italie] ; Katia Longo [Italie] ; Vincenzo Bonavita [Italie] ; Paolo Barone [Italie]Short‐term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross‐over trial

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Huntington Disease (drug therapy)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Huntington Disease (drug therapy)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Huntington Disease (drug therapy)
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024